Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 390

1.

Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing.

Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W.

JAMA Netw Open. 2018 Oct 5;1(6):e183605. doi: 10.1001/jamanetworkopen.2018.3605.

PMID:
30646252
2.

Can we trust observational data for clinical decision-making?

Nissen SE, Reed GW.

Eur Heart J. 2018 Dec 27. doi: 10.1093/eurheartj/ehy874. [Epub ahead of print] No abstract available.

PMID:
30597016
3.

High-Density Lipoprotein-Targeted Therapies-Not Dead Yet-Reply.

Nicholls SJ, Puri R, Nissen SE.

JAMA Cardiol. 2018 Nov 28. doi: 10.1001/jamacardio.2018.3973. [Epub ahead of print] No abstract available.

PMID:
30484832
4.

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial.

Menon V, Lincoff AM, Nicholls SJ, Jasper S, Wolski K, McGuire DK, Mehta CR, Rosenstock J, Lopez C, Marcinak J, Cao C, Nissen SE; GRAND 306 Investigators.

Diabetes Care. 2018 Dec;41(12):2603-2609. doi: 10.2337/dc18-0755.

PMID:
30459247
5.

Nonstatin Therapy for Dyslipidemia.

Ahmed HM, Nissen SE.

Circ Res. 2018 Oct 12;123(9):1036-1038. doi: 10.1161/CIRCRESAHA.118.313829. No abstract available.

PMID:
30355163
6.

Effect of Evolocumab on Coronary Plaque Composition.

Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJP, Koenig W, Somaratne R, Kassahun H, Yang J, Wasserman SM, Honda S, Shishikura D, Scherer DJ, Borgman M, Brennan DM, Wolski K, Nissen SE.

J Am Coll Cardiol. 2018 Oct 23;72(17):2012-2021. doi: 10.1016/j.jacc.2018.06.078.

PMID:
30336824
7.

Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

Nicholls SJ, Tuzcu EM, Wolski K, Johnson BD, Sopko G, Sharaf BL, Pepine CJ, Nissen SE, Bairey Merz CN.

Cardiovasc Diagn Ther. 2018 Aug;8(4):405-413. doi: 10.21037/cdt.2018.04.03.

8.

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.

Nicholls SJ, Lincoff AM, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Pedersen TR, Ridker PM, Ray K, Karlson BW, Lundström T, Wolski K, Nissen SE.

Clin Cardiol. 2018 Oct;41(10):1281-1288. doi: 10.1002/clc.23055. Epub 2018 Sep 28. Review.

9.

Randomized Trial Needed to Confirm Whether Dalcetrapib Improves Outcomes for Specific ADCY9 Genotype-Reply.

Nissen SE, Pillai SG.

JAMA Cardiol. 2018 Sep 1;3(9):897-898. doi: 10.1001/jamacardio.2018.2382. No abstract available.

PMID:
30090930
10.

Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial.

Nicholls SJ, Puri R, Ballantyne CM, Jukema JW, Kastelein JJP, Koenig W, Wright RS, Kallend D, Wijngaard P, Borgman M, Wolski K, Nissen SE.

JAMA Cardiol. 2018 Sep 1;3(9):806-814. doi: 10.1001/jamacardio.2018.2112.

PMID:
30046837
11.

Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial.

Nicholls SJ, Andrews J, Kastelein JJP, Merkely B, Nissen SE, Ray KK, Schwartz GG, Worthley SG, Keyserling C, Dasseux JL, Griffith L, Kim SW, Janssan A, Di Giovanni G, Pisaniello AD, Scherer DJ, Psaltis PJ, Butters J.

JAMA Cardiol. 2018 Sep 1;3(9):815-822. doi: 10.1001/jamacardio.2018.2121.

PMID:
30046828
12.

The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.

Solomon DH, Libby P, Yeomans ND, Wang Q, Wolski KE, Nissen SE, Husni ME.

Rheumatology (Oxford). 2018 Aug 1;57(8):1364-1369. doi: 10.1093/rheumatology/key105.

PMID:
29688503
13.

Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes.

Clark D 3rd, Nicholls SJ, St John J, Elshazly MB, Kapadia SR, Tuzcu EM, Nissen SE, Puri R.

Eur Heart J. 2018 Jul 14;39(27):2551-2558. doi: 10.1093/eurheartj/ehy209.

PMID:
29688308
14.

Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Vulnerable Plaque Features With Statin Therapy in Diabetic Patients With Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis.

Takata K, Kataoka Y, Andrews J, Puri R, Hammadah M, Duggal B, Kapadia SR, Tuzcu EM, Nissen SE, Nicholls SJ.

JACC Cardiovasc Imaging. 2018 Nov;11(11):1721-1723. doi: 10.1016/j.jcmg.2018.02.017. Epub 2018 Apr 18. No abstract available.

PMID:
29680344
15.

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.

Reed GW, Abdallah MS, Shao M, Wolski K, Wisniewski L, Yeomans N, Lüscher TF, Borer JS, Graham DY, Husni ME, Solomon DH, Libby P, Menon V, Lincoff AM, Nissen SE.

J Am Coll Cardiol. 2018 Apr 24;71(16):1741-1751. doi: 10.1016/j.jacc.2018.02.036.

PMID:
29673465
16.

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

Yeomans ND, Graham DY, Husni ME, Solomon DH, Stevens T, Vargo J, Wang Q, Wisniewski LM, Wolski KE, Borer JS, Libby P, Lincoff AM, Lüscher TF, Bao W, Walker C, Nissen SE; PRECISION investigators.

Aliment Pharmacol Ther. 2018 Jun;47(11):1453-1463. doi: 10.1111/apt.14610. Epub 2018 Apr 17.

PMID:
29667211
17.

Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial.

Yeomans ND, Graham DY, Wang Q, Wolski K, Borer J, Husni ME, Libby P, Lincoff AM, Lüscher T, Wisniewski LM, Bao W, Walker C, Nissen SE.

Am J Gastroenterol. 2018 Jul;113(7):1053-1054. doi: 10.1038/s41395-018-0051-6. No abstract available.

PMID:
29535414
18.

ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.

Nissen SE, Pillai SG, Nicholls SJ, Wolski K, Riesmeyer JS, Weerakkody GJ, Foster WM, McErlean E, Li L, Bhatnagar P, Ruotolo G, Lincoff AM.

JAMA Cardiol. 2018 May 1;3(5):401-408. doi: 10.1001/jamacardio.2018.0569.

PMID:
29525816
19.

Statin Denial: An Internet-Driven Cult With Deadly Consequences.

Nissen SE.

Ann Intern Med. 2018 Mar 6;168(5):381-382. doi: 10.7326/L17-0626. No abstract available.

PMID:
29507960
20.

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Thanh Hai MT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ; Standardized Data Collection for Cardiovascular Trials Initiative (SCTI).

J Am Coll Cardiol. 2018 Mar 6;71(9):1021-1034. doi: 10.1016/j.jacc.2017.12.048. Review.

PMID:
29495982

Supplemental Content

Loading ...
Support Center